BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25438063)

  • 1. The constitutive activation of Egr-1/C/EBPa mediates the development of type 2 diabetes mellitus by enhancing hepatic gluconeogenesis.
    Shen N; Jiang S; Lu JM; Yu X; Lai SS; Zhang JZ; Zhang JL; Tao WW; Wang XX; Xu N; Xue B; Li CJ
    Am J Pathol; 2015 Feb; 185(2):513-23. PubMed ID: 25438063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon, a key factor in the pathophysiology of type 2 diabetes.
    Girard J
    Biochimie; 2017 Dec; 143():33-36. PubMed ID: 29024725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
    Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.
    Ramakrishnan SK; Zhang H; Takahashi S; Centofanti B; Periyasamy S; Weisz K; Chen Z; Uhler MD; Rui L; Gonzalez FJ; Shah YM
    Cell Metab; 2016 Mar; 23(3):505-16. PubMed ID: 26853750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
    Lee P; Leong W; Tan T; Lim M; Han W; Radda GK
    Hepatology; 2013 Feb; 57(2):515-24. PubMed ID: 22911492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.
    Opherk C; Tronche F; Kellendonk C; Kohlmüller D; Schulze A; Schmid W; Schütz G
    Mol Endocrinol; 2004 Jun; 18(6):1346-53. PubMed ID: 15031319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.
    Erion DM; Kotas ME; McGlashon J; Yonemitsu S; Hsiao JJ; Nagai Y; Iwasaki T; Murray SF; Bhanot S; Cline GW; Samuel VT; Shulman GI; Gillum MP
    J Biol Chem; 2013 May; 288(22):16167-76. PubMed ID: 23595987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.
    Kodama H; Fujita M; Yamazaki M; Yamaguchi I
    Jpn J Pharmacol; 1994 Nov; 66(3):281-7. PubMed ID: 7869614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Egr-1 transcriptionally activates protein phosphatase PTP1B to facilitate hyperinsulinemia-induced insulin resistance in the liver in type 2 diabetes.
    Wu J; Tao W; Bu D; Zhao Y; Zhang T; Chong D; Xue B; Xing Z; Li C
    FEBS Lett; 2019 Nov; 593(21):3054-3063. PubMed ID: 31309546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
    Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
    Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice.
    Zhong Y; Jin J; Liu P; Song Y; Zhang H; Sheng L; Zhou H; Jiang B
    Oxid Med Cell Longev; 2020; 2020():6210526. PubMed ID: 31976031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sam68 promotes hepatic gluconeogenesis via CRTC2.
    Qiao A; Zhou J; Xu S; Ma W; Boriboun C; Kim T; Yan B; Deng J; Yang L; Zhang E; Song Y; Ma YC; Richard S; Zhang C; Qiu H; Habegger KM; Zhang J; Qin G
    Nat Commun; 2021 Jun; 12(1):3340. PubMed ID: 34099657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
    Park SA; Choi MS; Kim MJ; Jung UJ; Kim HJ; Park KK; Noh HJ; Park HM; Park YB; Lee JS; Lee MK
    J Ethnopharmacol; 2006 Oct; 107(3):412-7. PubMed ID: 16684593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
    Rizza RA
    Diabetes; 2010 Nov; 59(11):2697-707. PubMed ID: 20705776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.